UPSTREAM CONSULTING

Lobbying for RARE ACCESS ACTION PROJECT · reimbursement for rare disease patient care.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate · $15,000.00 income · posted Jul 17, 2026

Lobbying activity 1

Medicare/Medicaid

Protect Orphan Drug incentives.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem